Director of Surgical & Gastrointestinal Pathology, Lifespan AMC
Co-Director Molecular Pathology Core Facility
Professor of Pathology
Mresnick@lifespan.org
T: 401 444-4380
F: 401 444-8514
Rhode Island Hospital
Dept. of Pathology
APC
12-111
593 Eddy Street
Providence, RI 02903
Medical Education/Graduate Education:
MD/PhD, Hebrew University, Hadassah Medical School, Jerusalem, Israel; 1980-1989
Residency:
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; 1990-1993
Fellowship:
Gastrointestinal Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; 1992-1994
Pediatric Pathology, Children’s Hospital, Harvard Medical School, Boston, MA; 1994-1995
Board Certification:
1993 Anatomic Pathology
Research Interests:
Novel prognostic and diagnostic molecular markers in gastrointestinal malignancies; Image analysis as a tool in tumor diagnostics.
Current Approved Research Grants:
2002-2007 National Cancer for Research Resources, Center for Cancer Research Development-Molecular Pathology; Tissue Bank Research, Role: Co-Investigator
Most Recent Significant Publications:
Resnick, MB, Routhier, J, Konkin, T., Sabo, E, Pricolo, V (2004) Epidermal growth factor receptor, c-MET, beta-catenin and p53 expression in stage II colon cancer: A tissue microarray study. Clin Cancer Res 10:3069-75.
Resnick, MB, Konkin, T, Routhier, J, Sabo, E, Pricolo, VE (2005) Claudin-1 is a strong prognostic indicator in stage II colonic cancer: A tissue microarray study. Mod Pathol 18:511-518.
Kim, SS, Meitner, P, Konkin TA, Cho, YS, Resnick, MB, Moss, SF (2006) Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis. Mod Pathol 19:49-59.
Frable, W, Resnick, MB, DeLellis, R (2006). Molecular Pathology in: Principles and Practice of Surgical Pathology and Cytopathology. 4th ed..
